IDUA-HIRMAb fusion protein April 12, 2017 IDUA-HIRMAb fusion protein Trade Name Orphan Indication Mucopolysaccharidosis Type 1 (MPS) USA Market Approval USA USA Designation Date 2008-01-10 00:00:00 Sponsor ArmaGen Technologies, Inc.;914 Colorado Ave.;Santa Monica, California, 90401